Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu.

The biopharmaceutical company reaffirms its commitment to local innovation and manufacturing with the extension of the authorisation obtained in 2011. It will allow it to increase its current production capacity tenfold and boost its CDMO services.   The new manufacturing plant has obtained authorisation from the Spanish Agency for Medicines and Medical Devices for the…